HHGA
GSK icon

Halbert Hargrove Global Advisors’s GSK GSK Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42K Buy
+46
New +$2.43K ﹤0.01% 374
2025
Q4 		– Sell
-720
Closed -$31.1K – 530
2025
Q3 		$31.1K Buy
+720
New +$28.1K ﹤0.01% 212
2025
Q2 		– Sell
-13
Closed -$506 – 452
2025
Q1 		$506 Buy
+13
New +$476 ﹤0.01% 500

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Halbert Hargrove Global Advisors's GSK Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in GSK (GSK) in Q2 2026: 46 shares worth $2.42K. The stake represents ﹤0.01% of the portfolio and ranks #374 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in GSK as recently as Q3 2025.

Halbert Hargrove Global Advisors first reported a position in GSK in Q1 2025 and has held it in 3 quarters since. The position peaked at $31.1K in Q3 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Halbert Hargrove Global Advisors held 46 shares of GSK worth $2.42K as of Q2 2026.
  • GSK was a new Halbert Hargrove Global Advisors position in Q2 2026.
  • GSK made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #374 holding.
  • Halbert Hargrove Global Advisors first reported a position in GSK in Q1 2025 and has held it in 3 quarters since.
  • Halbert Hargrove Global Advisors's GSK position peaked at $31.1K in Q3 2025.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.